Transcriptional up-regulation of SOD1 by CEBPD: A potential target for cisplatin resistant human urothelial carcinoma cells
- 1 August 2010
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 80 (3), 325-334
- https://doi.org/10.1016/j.bcp.2010.04.007
Abstract
No abstract availableKeywords
Funding Information
- NATIONAL SCIENCE COUNCIL, Taipei, Taiwan (NSC95-2320-B-037-048, NSC97-2320-B-037-018-MY3)
- Kaohsiung Medical University, Kaohsiung, Taiwan (KMU-Q095018, KMU-Q096009, KMU-M097004, KMU-EM2)
This publication has 65 references indexed in Scilit:
- Inhibiting the Hypoxia Response for Cancer Therapy: The New Kid on the BlockClinical Cancer Research, 2009
- Epigenetic Silencing of CCAAT/Enhancer-binding Protein δ Activity by YY1/Polycomb Group/DNA Methyltransferase ComplexJournal of Biological Chemistry, 2008
- Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)British Journal of Cancer, 2008
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- The Cebpd (C/EBPδ) Gene Is Induced by Luteinizing Hormones in Ovarian Theca and Interstitial Cells But Is Not Essential for Mouse Ovary FunctionPLOS ONE, 2007
- Molecular mechanisms of resistance and toxicity associated with platinating agentsCancer Treatment Reviews, 2007
- C/EBP? is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cellsThe Prostate, 2005
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Regulation of Cu/Zn-Superoxide Dismutase Expression via the Phosphatidylinositol 3 Kinase/Akt Pathway and Nuclear Factor-κBJournal of Neuroscience, 2004
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003